The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: Results from the MALT clinical trial

Journal of the American Geriatrics Society

Volumn 48, Issue 3, 2000, Pages 268-274

  Shikiar, Richard ^a   Shakespeare, Annabelle ^b   Sagnier, Pierre Philippe ^c   Wilkinson, David ^d   McKeith, Ian ^e   Dartigues, Jean François ^f   Dubois, Bruno ^g  

^a MEDTAP International Inc   (United States)

^b Bayer plc UK   (United Kingdom)

^c BAYER AG   (Germany)

^d Thornhill Research Unit   (United Kingdom)

^e NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^f INSERM   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alzheimer's disease; Caregiver burden; Metrifonate; Randomized placebo controlled trial

Indexed keywords

METRIFONATE; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GERIATRIC CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STRESS;

EID: 0034121365     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb02645.x     Document Type: Article

References (55)

1. Haley WE. The family caregiver's role in Alzheimer's disease. Neurology 1997;48(suppl 6):S25-S29.
2. Schulz R, O'Brien AT, Bookwala J, Fleissner K. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist 1995;35:771-791.
3. Schulz R, Williamson GM. The measurement of caregiver outcomes in Alzheimer disease research. Alzheimer Dis Assoc Disord 1997;11(suppl 6):117-124.
4. Wright LK, Clipp EC, George LK. Health consequences of caregiver stress. Med Exerc Nutr Health 1993;2:181-195.
5. Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 1986;26:260-266.
6. Ory MG, Williams TF, Emr M et al. Families, informal supports, and Alzheimer's disease: current research and future agendas. Res Aging 1985;7: 623-644.
7. Hunter R, McGill L, Bosanquet N, Johnson N. Alzheimer's disease in the United Kingdom: developing patient and caregiver support strategies to encourage care in the community. Qual Health Care 1997;6:146-152.
8. Baumgarten M, Battista RN, Infante-Rivard C et al. Use of physician services among family caregivers of elderly persons with dementia. J Clin Epidemiol 1997;50:1265-1272.
9. Moss MS, Lawton PM, Kleban MH, Duhamel L. Time use of caregivers of impaired elders before and after institutionalization. J Gerontol 1993;48: S102-S111.
10. McFall S, Miller BH. Caregiver burden and nursing home admission of frail elderly persons. J Gerontol 1992;47:S73-S79.
11. Morycz RK. Caregiving strain and the desire to institutionalize family members with Alzheimer's disease. Res Aging 1985;7:329-361.
12. Colerick EJ, George LK. Predictors of institutionalization among caregivers of patients with Alzheimer's disease. J Am Geriatr Soc 1986;34:493-498.
13. O'Donnell BF, Drachman DA, Barnes HJ et al. Incontinence and trouble-some behaviors predict institutionalization in dementia. J Geriatr Psych Neurol 1992;5:45-57.
14. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer Disease. JAMA 1996;276:1725-1731.
15. Schulz R, Visintainer P, Williamson GM. Psychiatric and physical morbidity effects of caregiving. J Gerontol 1990;45:P181-P191.
16. Dunkin JJ, Anderson-Hanley C. Dementia caregiver burden: A review of the literature and guidelines for assessment and intervention. Neurology 1998; 51(suppl 1):353-360.
17. Pearlin LI, Mullan JT, Semple SJ, Skaff MM. Caregiving and the stress process: An overview of concepts and their measures. Gerontologist 1990;30: 583-594.
18. Aneshensel CS, Pearlin LI, Mullan JT, Zarit SH, Whitlatch CJ. Profiles in Caregiving: The Unexpected Career. San Diego, CA: Academic Press, 1995.
19. Baumgarten M. The health of persons giving care to the demented elderly: A critical review of the literature. J Clin Epidemiol 1989;42:1137-1148.
20. George LK, Gwyther LP. Caregiver well-being: A multidimensional examination of family caregivers of demented adults. J Gerontol 1986;26:253-259.
21. Robinson BC. Validation of a caregiver strain index. J Gerontol 1983;38: 344-348.
22. Poulshock SW, Deimling GT. Families caring for elders in residence: Issues in the measurement of burden. J Gerontol 1984;39:230-239.
23. Vitaliano PP, Russo J, Young HM, Becker J, Maiuro RD. The Screen for Caregiver Burden. Gerontologist 1991;31:76-83.
24. Greene JG, Smith R, Timbury GC. Measuring behavioral disturbance of elderly demented patients in the community and its effects on relatives: A factor analytic study. Age Ageing 1982;11:121-126.
25. Elmstahl S, Malmberg B, Annerstedt L. Caregiver's burden of patients 3 years after stroke assessed by a novel caregiver burden scale. Arch Phys Med Rehabil 1996;77:177-182.
26. Given CW, Given B, Stommel M, Collins C, King S, Franklin S. The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health 1992;15:271-283.
27. Stetz KM. Caregiving demands during advanced cancer. The spouse's needs. Cancer Nurs 1987;10:260-268.
28. Kosberg JI, Cairl RE. The cost of care index: a case management tool for screening informal care providers. Gerontologist 1986;26:273-278.
29. Todtman K, Gustafson AW. The financial impact scale: An instrument for assessing informal long-term caregivers. J Gerontol Soc Work 1991;18:135-149.
30. Given B, Stommel M, Collins C, King S, Given CW. Responses of elderly spouse caregivers. Res Nurs Health 1990;13:77-86.
31. Miller B, McFall S, Montgomery A. The impact of elder health, caregiver involvement, and global stress on two dimensions of caregiver burden. J Gerontol 1991;46:S9-S19.
32. Wells Y, Jorm AF. Evaluation of a special nursing home unit for dementia sufferers: A randomized controlled comparison with community care. Aust NZ J Psychiatry 1987;21:524-531.
33. Deimling GT. Caregiver functioning. In: Lawton MP, Teresi JA, eds. Annual Review of Gerontology and Geriatrics: Focus on Assessment Techniques, Vol. 14. New York: Springer Publishing Co., 1994, pp 257-280.
34. Vitaliano PP, Young HM, Russo J. Burden: A review of measures used among caregivers of individuals with dementia. Gerontologist 1991;31:67-75.
35. Clipp EC, Moore MJ. Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease. Clin Pharmacol Ther 1995;58:228-236.
36. Raskind MA, Cyrus PA, Ruzicka BB, Gulanski B. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group. J Clin Psychiatry 1999;60:318-325.
37. Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group. Neurology 1998;50:1214-1221.
38. Morris JC, Cyrus PA, Orazem J et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology 1998;50:1222-1230.
39. Dubois B, McKeith I, Orgogozo J-M, Collins O, Meulien D. A multicentre, randomised, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's Disease: The MALT study. Int J Geriatr Psych 1999; 14:973-982.
40. Folstein MF, Folstein SF, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinical. J Psychiatr Res 1975;12:189-198.
41. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
42. Mohs RC, Knopman D, Petersen RC et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope. Alzheimer Dis Assoc Disord 1997;11(suppl 2):S13-S21.
43. Food and Drug Administration Department of Health and Human Services, Correspondence, November 6, 1991.
44. F-D-C Reports. The Pink Sheet (Trade and Government Memos). March 2, 1992. Salem, MA: F-D-C Reports, Inc.
45. Cummings JL. The neuropsychiatric inventory: Assessing psychopathology in dementia patients. Neurology 1997;48(suppl 6):S10-S16.
46. Gélinas I, Auer S. Functional autonomy. In: S. Gauthier, ed. Clinical Diagnosis and Management of Alzheimer's Disease. London: Martin Dunitz Ltd., 1996, pp 191-199.
47. Busschbach JJV, Brouwer WBF, van der Donk A et al. An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease. Pharmacoeconomics 1998;13(1 Pt 1):21-34.
48. Kaufer DI, Cummings JL, Christine D et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: The Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 1998;46:210-215.
49. Montgomery RJV, Gonyea JG, Hooyman NR. Caregiving and the experience of subjective and objective burden. Family Relations 1985;34:19-26.
50. Acquadro C, Jambon B, Ellis D, Marquis P. Language and translation issues. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd Ed. New York: Lippincott Raven, 1996, pp 575-585.
51. European Group for Health Measurement and Quality of Life Assessment: Hung SM, Alonso J, Bucquet D, Niero M, Wiklund I, Mckenna S. Cross cultural adaptation of health measures. Health Policy 1996;19:33-34.
52. Cella DF, Wiklund SA, Shumaker SA, Aaronson NK. Integrating health-related quality of life into cross-national clinical trials. In: Shumaker SA, Berzon RA, eds. The International Assessment of Health-Related Quality of Life. Oxford: Rapid Communications, 1995.
53. Max W. The cost of Alzheimer's disease. Pharmacoeconomics 1996;9:5-10.
54. Gray A, Fenn P. Alzheimer's disease: The burden of illness in England. Health Trends 1993;25:31-37.
55. Welch HG, Walsh JS, Larson EB. The cost of institutional care in Alzheimer's disease: Nursing home and hospital use in a prospective cohort. J Am Geriatr Soc 1992;40:221-224.